These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Relationship of lipoprotein-associated phospholipase A2 and oxidized low density lipoprotein in carotid atherosclerosis. Vickers KC; Maguire CT; Wolfert R; Burns AR; Reardon M; Geis R; Holvoet P; Morrisett JD J Lipid Res; 2009 Sep; 50(9):1735-43. PubMed ID: 19359705 [TBL] [Abstract][Full Text] [Related]
11. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions. Häkkinen T; Luoma JS; Hiltunen MO; Macphee CH; Milliner KJ; Patel L; Rice SQ; Tew DG; Karkola K; Ylä-Herttuala S Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2909-17. PubMed ID: 10591668 [TBL] [Abstract][Full Text] [Related]
12. Simvastatin reduces lipoprotein-associated phospholipase A2 in lipopolysaccharide-stimulated human monocyte-derived macrophages through inhibition of the mevalonate-geranylgeranyl pyrophosphate-RhoA-p38 mitogen-activated protein kinase pathway. Song JX; Ren JY; Chen H J Cardiovasc Pharmacol; 2011 Feb; 57(2):213-22. PubMed ID: 21052011 [TBL] [Abstract][Full Text] [Related]
13. Utility of Lp-PLA2 in lipid-lowering therapy. Racherla S; Arora R Am J Ther; 2012 Mar; 19(2):115-20. PubMed ID: 20634673 [TBL] [Abstract][Full Text] [Related]
15. Amelioration of atherosclerosis in apolipoprotein E-deficient mice by inhibition of lipoprotein-associated phospholipase A2. Zhang H; Zhang JY; Sun TW; Shen DL; He F; Dang YH; Li L Clin Invest Med; 2013 Feb; 36(1):E32-41. PubMed ID: 23374598 [TBL] [Abstract][Full Text] [Related]
16. The role of lipoprotein-associated phospholipase a₂ as a marker and potential therapeutic target in atherosclerosis. Stewart RA; White HD Curr Atheroscler Rep; 2011 Apr; 13(2):132-7. PubMed ID: 21207201 [TBL] [Abstract][Full Text] [Related]
17. [Lp-PLA2, a biomarker of vascular inflammation and vulnerability of atherosclerosis plaques]. Bonnefont-Rousselot D Ann Pharm Fr; 2016 May; 74(3):190-7. PubMed ID: 26499399 [TBL] [Abstract][Full Text] [Related]
18. Evidence supporting a key role of Lp-PLA2-generated lysophosphatidylcholine in human atherosclerotic plaque inflammation. Gonçalves I; Edsfeldt A; Ko NY; Grufman H; Berg K; Björkbacka H; Nitulescu M; Persson A; Nilsson M; Prehn C; Adamski J; Nilsson J Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1505-12. PubMed ID: 22499993 [TBL] [Abstract][Full Text] [Related]
19. Simvastatin reduces expression and activity of lipoprotein-associated phospholipase A(2) in the aorta of hypercholesterolaemic atherosclerotic rabbits. Qiao Z; Ren J; Chen H J Int Med Res; 2009; 37(4):1029-37. PubMed ID: 19761685 [TBL] [Abstract][Full Text] [Related]
20. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?]. Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]